RBC Bioscience

RBC Bioscience Cash Flow per Share

The Operating Cash Flow per Share of RBC Bioscience (6848.TWO) as of Oct 21, 2026 is 4.25 TWD. In the previous year, Operating Cash Flow per Share was 1.01 TWD — a change of 318.57% (higher).

Cash Flow per Share

4.25TWD

YoY

318.57%

Last updated:

Operating Cash Flow per Share of RBC Bioscience is 2024 4.25 TWD. Operating Cash Flow per Share of RBC Bioscience was 2023 1.01 TWD. It decreases by 318.57% higher compared to the previous year.

The RBC Bioscience Cash Flow per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Flow per Share
Date
Cash Flow per Share
Jan 1, 2018
0.27 TWD
Jan 1, 2019
4.88 TWD
Jan 1, 2020
17.10 TWD
Jan 1, 2021
-2.06 TWD
Jan 1, 2022
0.51 TWD
Jan 1, 2023
1.01 TWD
Jan 1, 2024
4.25 TWD
The RBC Bioscience Cash Flow per Share history
YEARCash Flow per ShareYoY
4.25TWD+318.57%
1.01TWD+99.42%
0.51TWD-124.74%
-2.06TWD-112.03%
17.10TWD+250.71%
4.88TWD+1,673.97%
0.27TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RBC Bioscience Stock analysis

What does RBC Bioscience do? RBC Bioscience Corp manufactures reagents and devices for life science and molecular diagnosis. The company's products include instruments equipped with ultraviolet sterilization systems for nucleic acid purification and disposable reagent strips and tips that work with built-in control programs for different nucleic acid extraction types. The firm developed nucleic acid purification reagents with cellulose-embedded magnetic beads to improve DNA and RNA purity for blood, bacteria, viruses, and forensic examinations. These products are used for future diagnosis, prevention, tracking, and treatment of diseases. The company sells its instruments and reagents to customers in life science and molecular diagnosis sectors. The instruments feature ultraviolet sterilization systems, while the reagents include disposable strips and tips with varying control programs. The reagents with cellulose-embedded magnetic beads are designed for high-purity nucleic acid extraction from diverse samples including blood, bacteria, viruses, and forensic materials. RBC Bioscience Corp's revenue comes from the sale of instruments and reagents. The instruments are sold to laboratories and medical facilities requiring nucleic acid purification systems. The reagents, including the disposable strips and tips, are sold alongside the instruments or separately for ongoing use in molecular diagnosis processes. RBC Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RBC Bioscience stock

Operating Cash Flow per Share of RBC Bioscience is 4.25 TWD in 2024.

Operating Cash Flow per Share of RBC Bioscience changed from 1.01 TWD to 4.25 TWD, representing a 318.57% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow per Share RBC Bioscience since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow per share measures the operating cash generated per outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — RBC Bioscience

All Key Metrics — RBC Bioscience